美股A股
StockGist
Back
8-K2026-11-09· deepseek-v4-flash

TPB · Turning Point Brands, Inc.

0001437749-26-035713

SEC filing

Summary

TPB第三季度净销售额增长27.0%至$151.1 million,但净利大幅下滑81.4%,Modern Oral高增长与营销投入拖累盈利。

Key takeaways

Full analysis

指标本期去年同期同比
Net sales$151.1 million$119.0 million+27.0%
Gross profit$85.2 million$70.4 million+20.9%
Operating income$9.9 million$25.9 million-61.9%
Net income attributable to Turning Point Brands, Inc.$3.9 million$21.1 million-81.4%
Diluted EPS$0.19$1.13-83.2%
Adjusted Diluted EPS$0.41$1.05-61.0%
Adjusted EBITDA$18.4 million$31.3 million-41.3%
期间指标指引口径
FY 2026Modern Oral Gross Sales$330-$350 million—
FY 2026Modern Oral Net Sales$260-$270 million—
FY 2026Adjusted EBITDA$70-$80 millionNon-GAAP

增长引擎完全来自Modern Oral:Q3 Gross Sales增长114.2%至$93.9 million,Net Sales增长102.9%至$74.4 million,已占公司总净销售额49.2%;Stoker's分部净销售额增长52.0%至$113.8 million,而Zig-Zag分部净销售额下降15.5%至$37.3 million。产品结构向Modern Oral倾斜使Stoker's分部毛利率由60.2%降至56.0%,合并Gross profit虽增长20.9%至$85.2 million,但增速明显落后于收入。

利润端压力来自投入端:SG&A费用增长69.1%至$75.3 million,包含Modern Oral相关销售与营销投入及外运运费上升,直接导致Operating income下降至$9.9 million、Adjusted EBITDA下降41.3%至$18.4 million。管理层David Glazek强调对FRE与ALP的投资正在扩大分销并强化消费者互动,目标是成为快速增长的nicotine pouch品类领导者。公司重申2026全年Modern Oral Gross/Net Sales与Adjusted EBITDA指引,意味着当前的高投入被视为换取份额的阶段性成本;期末现金$251.3 million、净债务$48.7 million及总流动性$322.8 million为持续投入提供缓冲,但盈利兑现节奏仍是后续观察重点。